Mureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM Trial

Mureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM Trial

Randomized, sham-controlled trial shows Mureva OM significantly reduced severe oral mucositis BRECKSVILLE, Ohio, Sept. 10, 2026 /PRNewswire-PRWeb/ -- Mureva Phototherapy Inc. today announced that the U.S. Food and Drug Administration (FDA) granted De Novo authorization for Mureva OM™, and...